Guidances for opioid use in patients with chronic noncancer pain
Keywords:
chronic noncancer pain, treatment, opioids, guidancesAbstract
Background: Chronic pain is a disease which reduces quality of life to the patients who suffer its physical, psychological and social consequences. Patient evaluation and management focus on pain symptoms, functional disabilities, comorbidity and medication use or overuse. Treatment of chronic pain patient involves a comprehensive approach using medications and nonmedical treatmnet. Opioids could be useful and effective when are based on clear pain diagnosis and are carried out on the recommendations for chronic noncancer pain treatment with opioids.
Downloads
References
Niv D, Devor M. Chronic pain as a disease in its own right. Pain Practice 2004; 4: 179–81.
Bond M, Breivik H. Why pain control matters in a world full of killer diseases. Pain Clin Updates 2004; XII: 4.
Bond M, Breivik H. Pain relief as a human right. Pain Clin Updates 2004; XII: 5.
Siddall PJ, Cousins MJ. Persistant pain as a disease entity: Implications for clinical management. Anesth Analg 2004; 99: 510–20.
Harstall C, Ospina M. Pain Clin Update 2003; 11: 2.
Devor M, Wheeler S. Don’t suffer in scilence. EFIC Newsletter 2001; 10: 1–8.
Do-Quang-Cantagrel N, Wallace MS, Magnuson S. Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart review. Anesth Analg 2000; 90: 933–7.
France RD, Urban BJ, Keefe FJ. Long-term use narcotic analgesics in chronic pain. Soc Sci Med 1984; 19: 1379–82.
Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Management 1990; 5: S46–S62.
Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Management 1996; 11: 203–17.
Taub A. Opioid analgetics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins D, eds. Narcotic analgetics in anaesthesiology. Baltimore: Williams and Wilkins; 1982. p. 199–208.
Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Management 1992; 7: 69–77.
Passik SD, Weinreb HJ. Managing chronic non-malignant pain: overcoming obstacles to the use of opioids. Adv Ther 2000; 17: 70–83.
McQuay H. Opioids in pain management. Lancet 1999; 353: 2229–32.
Maier C, Hilderbrandt J, Klinger R, Heinrich-Eberl C, Lindena G. Morphine responsiveness, efficacy and tolerability in patient with chronic non-tumor associated pain-results of a double-blind placebo-controlled trial (MONTAS). Pain 2002; 97: 223–33.
Moulin D, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347: 143–7.
Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain 1999; 80: 453–62.
Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105: 71–8.
Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 174(11): 1589–94.
Kalso E, Edwards JE, Moore A, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372–80.
Palm S, Lehzen S, Mignat C, Steinmann J, Leimenstoll G, Maier C. Does prolonged treatment with sustained – release morphine tablets influence immune function? Anesth Analg 1998; 86: 166– 72.
Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980; 302: 123.
Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, et al. Endocrine consequences of long-term intratechal administration of opioids. J Clin Endocrinol Metab 2000; 85: 2215–22.
Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage 2003; 25: 38–47.
Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz UP. Neuropsychological effect of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003; 26: 913–21.
Vallow S, Ascher S, Vorsanger GJ, Katz NP. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003; 26: 913–21.
Kress GH, Kraft B. Opioid medication and driving ability. Eur J Pain 2005: 9: 141–4.
Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Are opioiddependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J Pain Symptom Manage 2003; 25: 559–77.
Canadian Pain Society. Use of opioid analgesics for the treatment of chronic non-cancer pain. A consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 1998; 3: 197–208.
Federation of State Medical Boards of US. Model guidelines for the use of controlled substances for the treatment of pain. Federation of State Medical Boards of the US, Inc. Euless, 1998.
Long SP. Pain subcommittee presents opioid and chronic pain guidelines to Medical Society of Virginia House of delegates at Annual Meeting. ASRA News, May 1998; 6–9.
Schug SA, Large RG. Opioids for chronic non-cancer pain. Pain Clin Updates. Seattle: IIASP Press 1995. p. 1–4.
A concensus Statement from the American Academy of Pain medicine and American Pain Society. The use of opioids for the treatment of chronic pain. Clin J Pain 1997; 13: 6–8.
Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf the Pain Society, the Royal Colledge of Anaesthtists, the Royal Colledge of General Practitioners and the Royal Colledge of Psychiatrists. Pain Society, 2004.
Kalso E, Allan L, Dellemijn P, Faura CC, Ilias WK, Jensen TS, et al. Recommendations for using opioids in chronic non-Cancer pain. Eur J Pain 2003; 7: 381–6.
Burk av opioider ved behandling av langvarige non-maligne smertetilstander. Statens legemiddelverk; Oslo 2002. Dosegljivo na: www.legemiddelverket.no/
Användning av opioider vid långvarig icke-cancerrelaterad smärta. Rekommendation: Läkemedelsverket, Uppsala 2006. Dosegljivo na: www.lakemedelsverket.se/
Anon. Core curriculum for professional education in pain. IASP Press 1995.
Saltzman RT, Roberts MS, Wild J, Fabian C, Reder RF, Goldenheim PD. Can a controlled release oral dose form of oxycodone be used really as an immediate-release form for the purpose of titrating to stable pain controlle? J Pain Symptom Manage 1999; 18: 271–9.
Gustorff B. Intravenous opioid testing in patients with chronic non-cancer pain. Eur J Pain 2005; 9: 123–5.
Schofferman J. Long-term opioid analgesic therapy for severe refractory lumbar spine pain. Clin J Pain 1999; 15: 136–40.
Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: A systematic review. J Pain Symptom Manage 2003; 26: 1026–48.
Downloads
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.